SeaStar Medical Holding (ICU) Other Accumulated Expenses (2021 - 2025)
SeaStar Medical Holding's (ICU) quarterly Other Accumulated Expenses came in at $241000.0 in Q2 2025, up 148.45% YoY from $97000.0 in Q2 2024, and down 23.97% on a QoQ basis from $317000.0 in Q1 2025.
SeaStar Medical Holding (ICU) Other Accumulated Expenses (2021 - 2025) Analysis & Trends
SeaStar Medical Holding (ICU) has 5 years of Other Accumulated Expenses data on file, last reported at $241000.0 in Q2 2025.
- Quarterly Other Accumulated Expenses rose 148.45% year-over-year to $241000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $241000.0 (up 148.45% YoY) and the FY2024 annual result came in at $383000.0, up 335.23% from the prior year.
- Other Accumulated Expenses eased to $241000.0 in Q2 2025, from $317000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $383000.0 in Q4 2024 to a low of $17000.0 in Q1 2024.
- A 5-year average of $155166.7 and a median of $109500.0 in 2022 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses plunged 76.06% — and 2025, when it jumped 1764.71%.
- Tracing ICU's Other Accumulated Expenses over 5 years: stood at $29000.0 in 2021, then soared by 320.69% to $122000.0 in 2022, then slipped by 27.87% to $88000.0 in 2023, then surged by 335.23% to $383000.0 in 2024, then tumbled by 37.08% to $241000.0 in 2025.
- The last three Other Accumulated Expenses figures came in at $241000.0 (Q2 2025), $317000.0 (Q1 2025), and $383000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 241,000.00 |
| Mar 31, 2025 | 317,000.00 |
| Dec 31, 2024 | 383,000.00 |
| Sep 30, 2024 | 281,000.00 |
| Jun 30, 2024 | 97,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 88,000.00 |
| Sep 30, 2023 | 159,000.00 |
| Jun 30, 2023 | 57,000.00 |
| Mar 31, 2023 | 71,000.00 |
| Dec 31, 2022 | 122,000.00 |
| Dec 31, 2021 | 29,000.00 |